Share Twitter LinkedIn Facebook Email Marlise R. Luskin, MD, MSCE, Johns Hopkins University School of Medicine, discusses Awaiting Phase 3 for Luspatercept and ASTX727 Clinical trial accrual is an ongoing challenge in MDS at Imedex Great Debates 2018.
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read
Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD Acute Lymphoblastic Leukemia 4 Mins Read
FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Acute Lymphoblastic Leukemia 3 Mins Read